Evidence map›Paper›PMID 24700100›Full record

ArticleThe Journal of general virology2014

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.

Geraldine Taylor, Sara Wyld, Jean-Francois Valarcher, Efrain Guzman, Michelle Thom, Stephanie Widdison, Ursula J Buchholz

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Small hydrophobic (SH) proteins ofJournal of virology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. International journal of molecular sciences · 2023
    Article
  11. The contribution of bovines to human health against viral infections.Environmental science and pollution research international · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Geraldine TaylorPirbright Institute, Woking, Surrey, GU24 0NF, UK.
Sara WyldPirbright Institute, Woking, Surrey, GU24 0NF, UK.
Jean-Francois ValarcherPirbright Institute, Woking, Surrey, GU24 0NF, UK.
Efrain GuzmanPirbright Institute, Woking, Surrey, GU24 0NF, UK.
Michelle ThomPirbright Institute, Woking, Surrey, GU24 0NF, UK.
Stephanie WiddisonPirbright Institute, Woking, Surrey, GU24 0NF, UK.
Ursula J BuchholzLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
The Pirbright Institute · GBNational Institute of Allergy and Infectious Diseases · US

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00001052Biotechnology and Biological Sciences Research Council BBS/E/I/00001325Biotechnology and Biological Sciences Research Council BBS/E/I/00001709Intramural NIH HHS
6 · The paper itself

Abstract

Bovine respiratory syncytial virus (BRSV) causes inflammation and obstruction of the small airways, leading to severe respiratory disease in young calves. The virus is closely related to human (H)RSV, a major cause of bronchiolitis and pneumonia in young children. The ability to manipulate the genome of RSV has provided opportunities for the development of stable, live attenuated RSV vaccines. The role of the SH protein in the pathogenesis of BRSV was evaluated in vitro and in vivo using a recombinant (r)BRSV in which the SH gene had been deleted. Infection of bovine epithelial cells and monocytes with rBRSVΔSH, in vitro, resulted in an increase in apoptosis, and higher levels of TNF-α and IL-1β compared with cells infected with parental, wild-type (WT) rBRSV. Although replication of rBRSVΔSH and WT rBRSV, in vitro, were similar, the replication of rBRSVΔSH was moderately reduced in the lower, but not the upper, respiratory tract of experimentally infected calves. Despite the greater ability of rBRSVΔSH to induce pro-inflammatory cytokines, in vitro, the pulmonary inflammatory response in rBRSVΔSH-infected calves was significantly reduced compared with that in calves inoculated with WT rBRSV, 6 days previously. Virus lacking SH appeared to be as immunogenic and effective in inducing resistance to virulent virus challenge, 6 months later, as the parental rBRSV. These findings suggest that rBRSVΔSH may be an ideal live attenuated virus vaccine candidate, combining safety with a high level of immunogenicity.

Indexed as

Genes, ViralAnimalsApoptosisCattleCattle DiseasesCytokinesGene DeletionHumansImmunity, MucosalInflammation MediatorsInterleukin-1betaRespiratory Syncytial Virus, BovineRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory SystemCytokinesInflammation MediatorsInterleukin-1betaRespiratory Syncytial Virus VaccinesRetroviridae Proteins, Oncogenicsmall hydrophobic protein, virusTumor Necrosis Factor-alphaVaccines, AttenuatedVaccines, Synthetic

Identifiers

PMID24700100
PMCPMC4027036
OpenAlexW2119157308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.